| ［1］ International Lymphoma Study Group. A clinical evaluation of the international lymphoma study group classification of nonHodgkin′s lymphoma. The nonHodgkin′s lymphoma classification project［J］. Blood, 1997, 89(11): 3909-3918. ［2］ Campo E, Swerdlow SH, Harris NL, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications［J］. Blood, 2011, 117(19): 5019-5032. ［3］ Dreyling M, ESMO Guidelines Working Group. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and followup［J］. Ann Oncol, 2009, 20 Suppl 4: 119-120. ［4］ Heinzelmann F, Engelhard M, Ottinger H, et al. Nodal follicular lymphoma: the role of radiotherapy for stages Ⅰ and Ⅱ［J］. Strahlenther Onkol, 2010, 186(4): 191-196. ［5］ Pugh TJ, Ballonoff A, Newman F, et al. Improved survival in patients with early stage lowgrade follicular lymphoma treated with radiation: a surveillance, epidemiology, and end results database analysis［J］. Cancer, 2010, 116(16): 3843-3851. ［6］ Dreyling M, Ghielmini M, Marcus R, et al. Newly diagnosed and relapsed follicular lymphoma: ESMO clinical practice guidelines for diagnosis, treatment and followup［J］. Ann Oncol, 2014, 25 Suppl 3: 76-82. ［7］ Dancey JE, Dodd LE, Ford R, et al. Recommendations for the assessment of progression in randomised cancer treatment trials［J］. Eur J Cancer, 2009, 45(2): 281-289. ［8］ Saad ED, Katz A. Progressionfree survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined［J］. Ann Oncol, 2009, 20(3): 460-464. ［9］ Eich HT, Heimann M, Stutzer H, et al. Longterm outcome and prognostic factors in earlystage nodal lowgrade nonhodgkin′s lymphomas treated with radiation therapy［J］. Strahlenther Onkol, 2009, 185(5): 288-295. ［10］ Tsang RW, Gospodarowicz MK. Lowgrade nonhodgkin lymphomas［J］. Semin Radiat Oncol, 2007, 17(3): 198-205. ［11］ Tsang RW, Gospodarowicz MK. Radiation therapy for localized lowgrade nonHodgkin′s lymphomas［J］. Hematol Oncol, 2005, 23(1): 10-17. ［12］ Gospodarowicz MK, Bush RS, Brown TC, et al. Prognostic factors in nodular lymphomas: a multivariate analysis based on the princess margaret hospital experience［J］. Int J Radiat Oncol Biol Phys, 1984, 10(4): 489-497. ［13］ Friedberg JW, Byrtek M, Link BK, et al. Effectiveness of firstline management strategies for stage Ⅰ follicular lymphoma: analysis of the national lymphoCare study［J］. J Clin Oncol, 2012, 30(27): 3368-3375. ［14］ WitzensHarig M, Hensel M, Unterhalt M, et al. Treatment of limited stage follicular lymphoma with rituximab immunotherapy and involved field radiotherapy in a prospective multicenter phase Ⅱ trialMIR trial［J］. BMC Cancer, 2011, 11: 87. ［15］ Lowry L, Smith P, Qian W, et al. Reduced dose radiotherapy for local control in nonHodgkin lymphoma: a randomised phase Ⅲ trial［J］. Radiother Oncol, 2011, 100(1): 86-92. |
